Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP1 | P03956 | 7/20 | 0.42 |
| ▸ | MMP8 | P22894 | 5/20 | 0.42 |
| ▸ | MMP13 | P45452 | 5/20 | 0.42 |
| ▸ | MMP7 | P09237 | 4/20 | 0.42 |
| ▸ | MMP12 | P39900 | 4/20 | 0.42 |
| ▸ | MEP1B | Q16820 | 2/20 | 0.42 |
| ▸ | BMP1 | P13497 | 2/20 | 0.41 |
| ▸ | MMP2 | P08253 | 2/20 | 0.40 |
| ▸ | MMP9 | P14780 | 2/20 | 0.40 |
| ▸ | MMP14 | P50281 | 1/20 | 0.40 |
| ▸ | MMP16 | P51512 | 1/20 | 0.40 |
| ▸ | MMP3 | P08254 | 8/20 | 0.39 |
| ▸ | CA2 | P00918 | 1/20 | 0.38 |
| ▸ | CA9 | Q16790 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL328649 | 0.86 | MMP1 (0.44) | MMP1MMP8MMP13MMP7MMP12 | |
| SCHEMBL6864692 | 0.85 | MMP3 (0.50) | MMP1MMP8MMP13MMP7MMP12 | |
| SCHEMBL6864397 | 0.85 | MMP1 (0.44) | MMP1MMP8MMP13MMP7MMP12 | |
| SCHEMBL6863163 | 0.85 | MMP1 (0.44) | MMP1MMP8MMP13MMP7MMP12 | |
| SCHEMBL6865083 | 0.85 | MMP1 (0.48) | MMP1MMP8MMP13MMP7MMP12 | |
| SCHEMBL328390 | 0.85 | MMP1 (0.43) | MMP1MMP8MMP13MMP7MMP12 | |
| SCHEMBL328407 | 0.85 | MMP1 (0.43) | MMP1MMP8MMP13MMP7MMP12 | |
| SCHEMBL6863166 | 0.84 | MMP1 (0.40) | MMP1MMP8MMP13MMP7MMP12 | |
| SCHEMBL328404 | 0.84 | BMP1 (0.43) | MMP1MMP8MMP13MMP7MMP12 | |
| SCHEMBL6863154 | 0.84 | MMP1 (0.40) | MMP1MMP8MMP13MMP7MMP12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2428509-A1 | Human adam-10 inhibitors | Symphony Evolution, Inc. (US) | 2012-03-14 | — | — | EP | disclosed |
| WO-2011041545-A1 | METHODS OF TREATING ANEURYSMAL DILATATION, BLOOD VESSEL WALL WEAKNESS AND SPECIFICALLY ABDOMINAL AORTIC AND THORACIC ANEURYSM USING MATRIX METALLOPROTEASE-2 INHIBITORS | SYMPHONY EVOLUTION, INC. (US) | 2011-04-07 | — | — | WO | disclosed |
| WO-2011011181-A1 | PHARMACOLOGICAL CHAPERONES FOR THE TREATMENT OF ALZHEIMER'S DISEASE | AMICUS THERAPEUTICS, INC. (US) | 2011-01-27 | — | — | WO | disclosed |